Literature DB >> 15195774

The case for insulin treatment early in type 2 diabetes.

Pasquale J Palumbo1.   

Abstract

Most patients with type 2 diabetes ultimately need insulin therapy. This paper presents the case for starting insulin therapy sooner rather than later, preferably without oral drugs and in a "basal/bolus" regimen consisting of a daily dose of a long-acting insulin for basal coverage plus preprandial doses of a short-acting insulin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15195774     DOI: 10.3949/ccjm.71.5.385

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  8 in total

1.  Novel views on new-onset diabetes after transplantation: development, prevention and treatment.

Authors:  Manfred Hecking; Johannes Werzowa; Michael Haidinger; Walter H Hörl; Julio Pascual; Klemens Budde; Fu L Luan; Akinlolu Ojo; Aiko P J de Vries; Esteban Porrini; Giovanni Pacini; Friedrich K Port; Adnan Sharif; Marcus D Säemann
Journal:  Nephrol Dial Transplant       Date:  2013-01-17       Impact factor: 5.992

Review 2.  Nocturnal hypoglycemia: answering the challenge with long-acting insulin analogs.

Authors:  Stephen A Brunton
Journal:  MedGenMed       Date:  2007-05-17

Review 3.  Diabetes care - insulin delivery in a changing world.

Authors:  Alan Marcus
Journal:  Medscape J Med       Date:  2008-05-20

4.  Cross tissue trait-pathway network reveals the importance of oxidative stress and inflammation pathways in obesity-induced diabetes in mouse.

Authors:  Shouguo Gao; Herbert Keith Roberts; Xujing Wang
Journal:  PLoS One       Date:  2012-09-17       Impact factor: 3.240

Review 5.  Intensification of insulin therapy in patients with type 2 diabetes mellitus: an algorithm for basal-bolus therapy.

Authors:  Martin J Abrahamson; Anne Peters
Journal:  Ann Med       Date:  2012-07-23       Impact factor: 4.709

Review 6.  Treating the elderly diabetic patient: special considerations.

Authors:  Louise Kezerle; Leah Shalev; Leonid Barski
Journal:  Diabetes Metab Syndr Obes       Date:  2014-08-28       Impact factor: 3.168

Review 7.  Treat-to-target trials: uses, interpretation and review of concepts.

Authors:  A J Garber
Journal:  Diabetes Obes Metab       Date:  2013-06-14       Impact factor: 6.577

8.  Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes.

Authors:  Lori Berard; Noreen Antonishyn; Kathryn Arcudi; Sarah Blunden; Alice Cheng; Ronald Goldenberg; Stewart Harris; Shelley Jones; Upender Mehan; James Morrell; Robert Roscoe; Rick Siemens; Michael Vallis; Jean-François Yale
Journal:  Diabetes Ther       Date:  2018-02-23       Impact factor: 2.945

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.